(Q58971203)
Statements
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate (English)
Robert Recker
Paul Miller
Darrell Fiske
Jerome Minkoff
Audrey Kriegman
Wenchun Zhou
Mathews Adera